The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2–glycero-3-phosphocholine and a thermosoftening carrier, e. The method comprises forming template-occluded primary metal-doped silicate particles having an amorphous structure and aggregating the particles into mesoporous agglomerates. An opening end of the primary communication passage, which opens on a side where the first armature chamber is located, is placed at a corresponding location of the armature, which is opposed to the spring chamber. The at least one second indicator is at least approximately the same as the at least one first indicator. The system also includes a merge tool that facilitates creating a configured file based on the original file, the stored information concerning the parameterized item, and the configuration choices for the parameterized item. The second component has a melting temperature of at least about 1450 C.